In this study, we sought to design small molecule inhibitors for the inhibition of SMYD3-mediated methylation (Figure 1), proliferation (Figure 3), colony formation (Figure S2), and viability (Figure S3) in breast cancer cells. This evidence concerns the gene SMYD3 and breast carcinoma.